Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrophage migration inhibitory factor MIF interferes with the Rb-E2F pathway.

Oleksi Petrenko1, Ute M Moll

  • 1Department of Pathology, Health Science Center, State University of New York at Stony Brook, Stony Brook, NY 11794, USA. apetrenko@notes.cc.sunysb.edu

Molecular Cell
|January 25, 2005
PubMed
Summary

Macrophage migration inhibitory factor (MIF) deficiency impairs E2F-driven cell growth and transformation resistance by affecting E2F4 function. This links inflammation, DNA replication, and tumorigenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Editorial Expression of Concern: p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity.

Cell research·2025
Same author

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Cell death and differentiation·2025
Same author

Intratumor heterogeneity in KRAS signaling shapes treatment resistance.

iScience·2025
Same author

Editor's Note: Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo.

Cancer research·2025
Same author

Corrigendum: TAp73 is a central transcriptional regulator of airway multiciliogenesis.

Genes & development·2024

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Macrophage migration inhibitory factor (MIF) regulates inflammation and cell growth.
  • MIF modulates p53 and E2F pathways in response to oncogenic signaling.
  • Chronic inflammation is linked to increased tumorigenesis.

Purpose of the Study:

  • To characterize the functional link between MIF and E2F transcription factors.
  • To investigate the role of MIF in oncogenic transformation.
  • To elucidate the molecular mechanisms underlying the association between inflammation and cancer.

Main Methods:

  • Cellular assays to assess growth alterations in MIF-deficient cells.
  • Analysis of E2F4 C-terminal domain function and Rb binding.
  • Genetic manipulation (inactivation of Rb, domain substitution) to rescue transformation defects.

Related Experiment Videos

Main Results:

  • MIF-deficient cells show E2F-dependent growth alterations and reduced oncogenic transformation.
  • Perturbed function of the E2F4 C-terminal Rb binding region underlies transformation resistance.
  • Rb inactivation or E2F4 domain substitution rescues the transformation defect.
  • E2F's role in DNA replication, not transcription, is critical for oncogenesis in MIF deficiency.

Conclusions:

  • MIF deficiency confers resistance to oncogenic transformation through altered E2F4 function.
  • The interplay between MIF, E2F, DNA replication, and tumor suppression is crucial.
  • This study provides a molecular link between chronic inflammation and tumorigenesis.